Bristol-Myers Squibb Canada Co. et al. v Sandoz Canada Inc.
2019
T-504-19
Resolved
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,461,202 (apixaban)
Counsel to:
Sandoz Canada Inc.
The decision is reported
here.
Meet the team
![Carol Hitchman](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0b350718f350133b0bea2_carol-website-bw-min.jpg)
Carol Hitchman
Counsel
![Nathaniel Dillonsmith](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0bab4006d422e2353fe2b_nathaniel-bw-min.jpeg)
Nathaniel Dillonsmith
Associate